Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35881132.
- Also identified by DOI 10.1001/jama.2022.9734 and PMC identifier 9327580.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines the frequency of product recalls and the presence of FDA-prohibited drugs in supplements after FDA warning letters.
Medical subject headings
- Dietary Supplements
- Drug Recalls
- United States Food and Drug Administration